10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab.

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To identify baseline peripheral blood biomarkers associated with clinical outcome following ipilimumab treatment in advanced melanoma patients.

          Related collections

          Author and article information

          Journal
          Clin. Cancer Res.
          Clinical cancer research : an official journal of the American Association for Cancer Research
          1078-0432
          1078-0432
          Jun 15 2016
          : 22
          : 12
          Affiliations
          [1 ] Department of Dermatology, University Medical Center, Tübingen, Germany. Department of Internal Medicine II, University Medical Center, Tübingen, Germany.
          [2 ] The Netherlands Cancer Institute, Amsterdam, the Netherlands.
          [3 ] Memorial Sloan Kettering Cancer Center, New York, New York.
          [4 ] Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York.
          [5 ] Department of Oncology, Service of Medical Oncology, Research Unit 932, Institut Curie, Paris, France.
          [6 ] Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France.
          [7 ] Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy.
          [8 ] Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy.
          [9 ] Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. German Cancer Consortium (DKTK), Heidelberg, Germany.
          [10 ] German Cancer Consortium (DKTK), Heidelberg, Germany. Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
          [11 ] Department of Dermatology, University Medical Center, Tübingen, Germany.
          [12 ] Departments of Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany.
          [13 ] Department of Internal Medicine II, University Medical Center, Tübingen, Germany.
          [14 ] Department of Dermatology, University Medical Center, Tübingen, Germany. Department of Immunology, University of Tübingen, Tübingen, Germany. benjamin.weide@med.uni-tuebingen.de.
          Article
          1078-0432.CCR-15-2412
          10.1158/1078-0432.CCR-15-2412
          26787752
          6548e161-48ec-4913-b412-d00d9cb37dc1
          ©2016 American Association for Cancer Research.
          History

          Comments

          Comment on this article